Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Retained Earnings: 2017-2019

Historic Retained Earnings for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to -$217.0 million.

  • Astria Therapeutics' Retained Earnings fell 13.46% to -$217.0 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$217.0 million, marking a year-over-year decrease of 13.46%. This contributed to the annual value of -$197.3 million for FY2018, which is 15.09% down from last year.
  • According to the latest figures from Q3 2019, Astria Therapeutics' Retained Earnings is -$217.0 million, which was down 3.09% from -$210.5 million recorded in Q2 2019.
  • Astria Therapeutics' Retained Earnings' 5-year high stood at -$151.9 million during Q1 2017, with a 5-year trough of -$217.0 million in Q3 2019.
  • For the 3-year period, Astria Therapeutics' Retained Earnings averaged around -$184.7 million, with its median value being -$185.6 million (2018).
  • Data for Astria Therapeutics' Retained Earnings shows a maximum YoY dropped of 17.86% (in 2018) over the last 5 years.
  • Astria Therapeutics' Retained Earnings (Quarterly) stood at -$171.4 million in 2017, then fell by 15.09% to -$197.3 million in 2018, then declined by 13.46% to -$217.0 million in 2019.
  • Its Retained Earnings stands at -$217.0 million for Q3 2019, versus -$210.5 million for Q2 2019 and -$203.3 million for Q1 2019.